8-(4-(1-Ethylpiperidin-4-yl)-1H-pyrazol-1-yl)pyrido[3,4-d]pyrimidin-4(3H)-one

ID: ALA4560811

PubChem CID: 155558505

Max Phase: Preclinical

Molecular Formula: C17H20N6O

Molecular Weight: 324.39

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCN1CCC(c2cnn(-c3nccc4c(=O)[nH]cnc34)c2)CC1

Standard InChI:  InChI=1S/C17H20N6O/c1-2-22-7-4-12(5-8-22)13-9-21-23(10-13)16-15-14(3-6-18-16)17(24)20-11-19-15/h3,6,9-12H,2,4-5,7-8H2,1H3,(H,19,20,24)

Standard InChI Key:  CLDDHWNJFOWJLH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
   10.9151   -3.3017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9140   -4.1213    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6220   -4.5302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6202   -2.8929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3288   -3.2981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3296   -4.1172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0381   -4.5242    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.7464   -4.1134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7417   -3.2913    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.0325   -2.8879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6244   -5.3450    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9644   -5.8269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2187   -6.6035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0360   -6.6016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2866   -5.8239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0282   -2.0707    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5228   -7.2616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1901   -8.0090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6683   -8.6673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4816   -8.5841    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.8144   -7.8366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3338   -7.1724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9610   -9.2458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6276   -9.9919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10  5  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
  3 11  1  0
 10 16  2  0
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 14 17  1  0
 20 23  1  0
 23 24  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4560811

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 324.39

Molecular Weight (Monoisotopic): 324.1699

AlogP: 1.70

#Rotatable Bonds: 3

Polar Surface Area: 79.70

Molecular Species: BASE

HBA: 6

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 10.06

CX Basic pKa: 8.89

CX LogP: 0.73

CX LogD: -0.50

Aromatic Rings: 3

Heavy Atoms: 24

QED Weighted: 0.79

Np Likeness Score: -1.25

References

1. Le Bihan YV, Lanigan RM, Atrash B, McLaughlin MG, Velupillai S, Malcolm AG, England KS, Ruda GF, Mok NY, Tumber A, Tomlin K, Saville H, Shehu E, McAndrew C, Carmichael L, Bennett JM, Jeganathan F, Eve P, Donovan A, Hayes A, Wood F, Raynaud FI, Fedorov O, Brennan PE, Burke R, van Montfort RLM, Rossanese OW, Blagg J, Bavetsias V..  (2019)  C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.,  177  [PMID:31158747] [10.1016/j.ejmech.2019.05.041]

Source

Source(1):

• Scientific Literature